Login Register Cart 0
Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Potential Angiotensin Converting Enzyme Inhibitors from Moringa oleifera

Author(s): Huma Khan, Varun Jaiswal, Saurabh Kulshreshtha and Azhar Khan*

Volume 13, Issue 3, 2019

Page: [239 - 248] Pages: 10

DOI: 10.2174/1872208313666190211114229

Price: $65

Abstract

Background: Hypertension is the chronic medical condition and it affected billions of people worldwide. Natural medicines are the main alternatives to treatment for a majority of people suffering from hypertension. Niazicin-A, Niazimin-A, and Niaziminin-B compounds from Moringa oleifera ethanolic leave extract were reported to have potent antihypertensive activity.

Objective: These compounds were targeted with Angiotensin-converting enzyme [ACE] which is one of the main regulatory enzymes of the renin-angiotensin system.

Methods: Protein-ligand docking of these compounds with [ACE] [both domain N and C] was conceded out through Autodock vina and visualization was done by chimera. Pharmacokinetics study of these compounds was predicted by ADME-Toxicity Prediction.

Results: Niazicin-A, Niazimin-A, and Niaziminin-B showed high binding affinity with ACE and partially blocked the active sites of the enzyme. Niazicin-A, Niazimin-A and Niaziminin-B showed the estimated free binding energy of -7.6kcal/mol kcal/mol, -8.8kcal/mol and -8.0kcal/mol respectively with C-domain of ACE and -7.9kcal/mol, -8.5kcal/mol and -7.7kcal/mol respectively with N-domain of ACE. The compounds showed better binding energy with angiotensinconverting enzyme in comparison to Captopril -5.5kcal/mol and -5.6kcal/mol and Enalapril [standard] -8.4kcal/mol and -7.5kcal/mol with C and N domain, respectively.

Conclusion: Computationally, the selected bioactive molecules have shown better binding energy to known standard drugs which have been already known for inhibition of ACE and can further act as a pharmacophore for in vitro and in vivo studies in the development of alternative medicine.

Keywords: Docking, hypertension, autodock vina, angiotensin converting enzyme, Niazicin-A, Niazimin-A, Niaziminin-B, captopril, and Moringa oleifera.

« Previous Next »
Graphical Abstract

[1]
Peart WS. Renin-angiotensin system. N Engl J Med 1975; 292: 302-6.
[2]
Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-70.
[3]
Donoghue M, Hsieh F, Baronas E, Godbout K, et al. A novel angiotensin-converting enzyme–related carboxypeptidase [ACE2] converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: 1-9.
[4]
Yusuf S, Sleight PE, Pogue JF, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53.
[5]
Jong Eo Ji HP, Eig SO. Moringa oleifera preparation method thereof. KR20180120293A, 2018.
[6]
Osamu I, Fumino M, Toshihiko O. Angiotensin converting enzyme inhibitor. JP2001172191A, 2001.
[7]
Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev 2011; 5: 30.
[8]
Ranilla LG, Kwon YI, Apostolidis E, et al. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycaemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol 2010; 101: 4676-89.
[9]
Eddouks M, Maghrani M, Lemhadri A. Ethno pharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco [Tafilalet]. J Ethnopharmacol 2001; 82: 97-103.
[10]
Wen P. Moringa oleifera health care product capable of relieving hypertension, hyperglycaemia and hyperlipidaemia, and preparation method thereof. CN106360698A, 2017.
[11]
Kajihara R, Nakatsu S, Shiono T, Ishihara M. Antihypertensive effect of water extracts from leaves of Moringa oleifera Lam. on spontaneously hypertensive rats. J Jap Soc Food Sci 2008; 55: 183-5.
[12]
Gilani AH, Aftab K, Suria A, et al. Pharmacological studies on hypotensive and spasmolytic activities of pure compounds from Moringa oleifera. Phytother Res 1994; 8: 87-91.
[13]
Faizi S, Siddiqui BS, Saleem R, et al. Hypotensive constituents from the pods of Moringa oleifera. Planta Med 1998; 64: 225-8.
[14]
Corradi HR, Schwager SL, Nchinda AT, et al. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol 2006; 357: 964-74.
[15]
Natesh R, Schwager SL, Sturrock ED, et al. Crystal structure of the human angiotensin-converting enzyme–lisinopril complex. Nature 2003; 421: 551.
[16]
Muhammad SA, Fatima N. In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn Mag 2015; 11: 123.
[17]
Kashyap M, Jaiswal V, Farooq U. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach. Infect Genet Evol 2017; 53: 107-15.
[18]
Ghersi D, Singh M. mol BLOCKS: decomposing small molecule sets and uncovering enriched fragments. Bioinformatics 2014; 30: 2081-3.
[19]
Hisle MS, Meier MS, Toth DM. Accelerating autodock vina with containerization. Proceedings of the Practice and Experience on Advanced Research Computing. Pittsburgh, PA, USA. 2018.
[20]
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455-61.
[21]
Chauhan D, Jaiswal V. An efficient data mining classification approach for detecting lung cancer disease. International Conference on Communication and Electronics Systems. Coimbatore, India. 2016.
[22]
Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-12.
[23]
Awaluddin R, Muhtadi WK, Chabib L, Ikawati Z, Martien R, Ismail H. Molecular docking and ADME-toxicity studies of potential compounds of medicinal plants grown in Indonesia as an anti-rheumatoid arthritis. AIP Conf Proc 2017; 1823020033
[24]
Zhang D, Jiang S. Moringa oleifera composition for reducing blood pressure and preparation method of Moringa oleifera composition. CN104957474A. 2015.
[25]
Saini RK, Sivanesan I, Keum YS. Phytochemicals of Moringa oleifera: a review of their nutritional, therapeutic and industrial significance. 3 Biotech 2016 6: 203.
[26]
Swales JD. Renin-angiotensin system in hypertension. Pharmacol Ther 1979; 7: 173-201.
[27]
Cooper R, McFarlane-Anderson N, Bennett FI, et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107.
[28]
Al Disi SS, Anwar MA, Eid AH. Anti-hypertensive herbs and their mechanisms of action: part I. Front Pharmacol 2016; 6: 323.
[29]
Pandey A, Pandey RD, Tripathi P, et al. Moringa oleifera Lam. Sahijan-a plant with a plethora of diverse therapeutic benefits: an updated retrospection. J Med Aromat Plants 2012; 1: 1-8.
[30]
Wadhwa S. A review on commercial, traditional uses, phytoconstituent and pharmacological activity of Moringa oleifera. Glob J Trad Med 2013; 2: 01-13.
[31]
Hafeez A, Askari H, Khan N, et al. Molecular modeling of plant flavonoids as angiotensin converting enzyme (ACE) inhibitors in hypertension: a docking study. World J Pharm Sci 2014; 2: 499-506.
[32]
Delmondes P, Benício R. In silico study of the natural compounds inhibiting angiotensin converting enzyme II. Int Conf Multidiscipl Sci 2017; 3: 1-7.
[33]
Feng Y, Xia H, Santos RA, Speth R, Lazartigues E. Angiotensin‐converting enzyme 2: a new target for neurogenic hypertension. Exp Physiol 2010; 95: 601-6.
[34]
Chauhan D, Jaiswal V. Development of computational tool for lung cancer prediction using data mining. Int J Comput Appl Technol Res 2016; 5(17): 417-21.

Rights & Permissions Print Cite
Article Metrics
40
5
© 2024 Bentham Science Publishers | Privacy Policy